Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion

por Postma, Maarten, Fisman, David, Giglio, Roberto, Márquez-Peláez, Sergio, Nguyen, Van Hung, Pugliese, Andrea, Ruíz-Aragón, Jesús, Urueña, Analía, Mould-Quevedo, Joaquín
Publicado 2024